Company

Nanorepro AG

Headquarters: Marburg, Germany

Employees: 14

CEO: Ms. Lisa Jungst

Market Cap

€32.7 Million

EUR as of Jan. 1, 2023

US$34.9 Million

history Market Cap History

Nanorepro AG market capitalization over time

Evolution of Nanorepro AG market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of Nanorepro AG

Detailed Description

NanoRepro AG develops, manufactures, and distributes rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. It provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. The company offers rapid diagnostic tests, including allergy, family planning, and preventive healthcare line products; point of care testing products for hospitals and medical practices for detection of HIV, human cardiac Troponin I, D-dimer, streptococci antigen, influenza type A and B antigens, and microalbumin; and immunochromatographic lateral flow tests for the diagnostic detection of biomarkers, as well as rapid SARS-CoV-2 antibody test and corona antigen rapid test. It also provides food supplements for men and women through online shops, as well as through pharmacies. The company is headquartered in Marburg, Germany.

Stocks & Indices

Nanorepro AG has the following listings and related stock indices.


Stock: FSX: NN6

Stock: XETR: NN6

Details

Headquarters:

Untergasse 8

Marburg, 35037

Germany

Phone: 49 6421 951449

Fax: 49 6421 951451